Institutional shares held 117 Million
442K calls
149K puts
Total value of holdings $1.63B
$6.19M calls
$2.09M puts
Market Cap $1.33B
95,046,400 Shares Out.
Institutional ownership 122.72%
# of Institutions 330


Latest Institutional Activity in TXG

Top Purchases

Q2 2025
Aqr Capital Management LLC Shares Held: 4.14M ($58M)
Q2 2025
Wellington Management Group LLP Shares Held: 1.89M ($26.5M)
Q2 2025
Quantinno Capital Management LP Shares Held: 2.23M ($31.3M)
Q2 2025
Vanguard Group Inc Shares Held: 12.4M ($174M)
Q2 2025
Jacobs Levy Equity Management, Inc Shares Held: 2.4M ($33.6M)

Top Sells

Q2 2025
Ubs Asset Management Americas Inc Shares Held: 263K ($3.68M)
Q2 2025
Millennium Management LLC Shares Held: 2.88M ($40.4M)
Q2 2025
Deerfield Management Company, L.P. (Series C) Shares Held: 11.3K ($158K)
Q2 2025
Ra Capital Management, L.P. Shares Held: 475K ($6.66M)
Q2 2025
D. E. Shaw & Co., Inc. Shares Held: 746K ($10.5M)

About TXG

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.


Insider Transactions at TXG

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
822K Shares
From 11 Insiders
Grant, award, or other acquisition 720K shares
Open market or private purchase 40K shares
Exercise of conversion of derivative security 62K shares
Sell / Disposition
97.3K Shares
From 4 Insiders
Open market or private sale 90.1K shares
Bona fide gift 7.2K shares

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG